Related Experiment Video
Updated: Aug 17, 2026
07:52
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
Identification of lymphoma-associated antigens using SEREX
Amanda P Liggins1, Barbara A Guinn, Alison H Banham
1Nuffield Department of Clinical Laboratory Sciences, University of Oxford, UK.
Methods in Molecular Medicine
|July 7, 2005
Summary
Serological analysis of recombinant complementary deoxyribonucleic acid (cDNA) expression libraries (SEREX) identifies cancer-associated proteins. This method uses patient antibodies to find disease-specific antigens for diagnostics and immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Serological analysis of recombinant complementary deoxyribonucleic acid (cDNA) expression libraries (SEREX) is a key method for identifying cancer-associated proteins.
- Naturally occurring antibodies in cancer patient serum can be leveraged to detect these immunogenic proteins.
Purpose of the Study:
- To detail the SEREX methodology for identifying cancer-associated antigens.
- To highlight the potential of these antigens as diagnostic markers and immunotherapy targets.
Main Methods:
- Screening of a relevant cDNA expression library using patient serum pre-cleared of bacterial/viral antibodies.
- Confirmation of antigen reactivity through a second screening round.
- Sequencing and identification of genes encoding confirmed antigens.
- Screening identified antigens with allogeneic sera from patients and controls to find disease-specific markers.
Main Results:
- Identification of immunogenic cancer-associated proteins.
- Confirmation of antigen reactivity and specificity.
- Potential discovery of novel disease-specific antigens.
Conclusions:
- SEREX is a robust technique for identifying cancer-specific antigens.
- Identified antigens can serve as valuable diagnostic markers.
- These antigens hold promise as targets for cancer immunotherapy.
